Humacyte, Inc. (HUMA) closed the most recent trading day at $0.78, moving -2.32% from the previous trading session. This change lagged the S&P 500's 0.79% gain on the day. Meanwhile, the Dow ...

Humacyte, Inc. (HUMA) concluded the recent trading session at $0.62, signifying a -11.14% move from its prior day's close.

Humacyte said it will use the money to support sales of its recently FDA-approved product Symvess and prepare an application for FDA approval of its vessel in dialysis patients, a ...

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often ...

In the latest market close, Humacyte, Inc. (HUMA) reached $5.05, with a -1.94% movement compared to the previous day. The stock's change was less than the S&P 500's daily loss of 1.86%. Meanwhile, the ...

Humacyte, Inc. (HUMA) ended the recent trading session at $1.03, demonstrating a -3.74% change from the preceding day's closing price. The stock's performance was behind the S&P 500's daily loss of ...

Affiliated Managers Group (AMG) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is ...